1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-fungal Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Powder
1.2.3 Ointment
1.2.4 Tablet
1.2.5 Other
1.3 Market by Application
1.3.1 Global Anti-fungal Drugs Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-fungal Drugs Market Perspective (2018-2029)
2.2 Anti-fungal Drugs Growth Trends by Region
2.2.1 Anti-fungal Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anti-fungal Drugs Historic Market Size by Region (2018-2023)
2.2.3 Anti-fungal Drugs Forecasted Market Size by Region (2024-2029)
2.3 Anti-fungal Drugs Market Dynamics
2.3.1 Anti-fungal Drugs Industry Trends
2.3.2 Anti-fungal Drugs Market Drivers
2.3.3 Anti-fungal Drugs Market Challenges
2.3.4 Anti-fungal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-fungal Drugs Players by Revenue
3.1.1 Global Top Anti-fungal Drugs Players by Revenue (2018-2023)
3.1.2 Global Anti-fungal Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Anti-fungal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-fungal Drugs Revenue
3.4 Global Anti-fungal Drugs Market Concentration Ratio
3.4.1 Global Anti-fungal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-fungal Drugs Revenue in 2022
3.5 Anti-fungal Drugs Key Players Head office and Area Served
3.6 Key Players Anti-fungal Drugs Product Solution and Service
3.7 Date of Enter into Anti-fungal Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-fungal Drugs Breakdown Data by Type
4.1 Global Anti-fungal Drugs Historic Market Size by Type (2018-2023)
4.2 Global Anti-fungal Drugs Forecasted Market Size by Type (2024-2029)
5 Anti-fungal Drugs Breakdown Data by Application
5.1 Global Anti-fungal Drugs Historic Market Size by Application (2018-2023)
5.2 Global Anti-fungal Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Anti-fungal Drugs Market Size (2018-2029)
6.2 North America Anti-fungal Drugs Market Size by Country (2018-2023)
6.3 North America Anti-fungal Drugs Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Anti-fungal Drugs Market Size (2018-2029)
7.2 Europe Anti-fungal Drugs Market Size by Country (2018-2023)
7.3 Europe Anti-fungal Drugs Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-fungal Drugs Market Size (2018-2029)
8.2 Asia-Pacific Anti-fungal Drugs Market Size by Country (2018-2023)
8.3 Asia-Pacific Anti-fungal Drugs Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Anti-fungal Drugs Market Size (2018-2029)
9.2 Latin America Anti-fungal Drugs Market Size by Country (2018-2023)
9.3 Latin America Anti-fungal Drugs Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-fungal Drugs Market Size (2018-2029)
10.2 Middle East & Africa Anti-fungal Drugs Market Size by Country (2018-2023)
10.3 Middle East & Africa Anti-fungal Drugs Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Anti-fungal Drugs Introduction
11.1.4 Abbott Laboratories Revenue in Anti-fungal Drugs Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Anti-fungal Drugs Introduction
11.2.4 Astellas Pharma Revenue in Anti-fungal Drugs Business (2018-2023)
11.2.5 Astellas Pharma Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Anti-fungal Drugs Introduction
11.3.4 Bayer Revenue in Anti-fungal Drugs Business (2018-2023)
11.3.5 Bayer Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Anti-fungal Drugs Introduction
11.4.4 GlaxoSmithKline Revenue in Anti-fungal Drugs Business (2018-2023)
11.4.5 GlaxoSmithKline Recent Development
11.5 Glenmark
11.5.1 Glenmark Company Detail
11.5.2 Glenmark Business Overview
11.5.3 Glenmark Anti-fungal Drugs Introduction
11.5.4 Glenmark Revenue in Anti-fungal Drugs Business (2018-2023)
11.5.5 Glenmark Recent Development
11.6 Kramer Laboratories
11.6.1 Kramer Laboratories Company Detail
11.6.2 Kramer Laboratories Business Overview
11.6.3 Kramer Laboratories Anti-fungal Drugs Introduction
11.6.4 Kramer Laboratories Revenue in Anti-fungal Drugs Business (2018-2023)
11.6.5 Kramer Laboratories Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Anti-fungal Drugs Introduction
11.7.4 Merck Revenue in Anti-fungal Drugs Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Anti-fungal Drugs Introduction
11.8.4 Novartis Revenue in Anti-fungal Drugs Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Anti-fungal Drugs Introduction
11.9.4 Pfizer Revenue in Anti-fungal Drugs Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 SCYNEXIS
11.10.1 SCYNEXIS Company Detail
11.10.2 SCYNEXIS Business Overview
11.10.3 SCYNEXIS Anti-fungal Drugs Introduction
11.10.4 SCYNEXIS Revenue in Anti-fungal Drugs Business (2018-2023)
11.10.5 SCYNEXIS Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Anti-fungal Drugs Introduction
11.11.4 Sanofi Revenue in Anti-fungal Drugs Business (2018-2023)
11.11.5 Sanofi Recent Development
11.12 Gilead Science
11.12.1 Gilead Science Company Detail
11.12.2 Gilead Science Business Overview
11.12.3 Gilead Science Anti-fungal Drugs Introduction
11.12.4 Gilead Science Revenue in Anti-fungal Drugs Business (2018-2023)
11.12.5 Gilead Science Recent Development
11.13 Enzon Pharmaceuticals
11.13.1 Enzon Pharmaceuticals Company Detail
11.13.2 Enzon Pharmaceuticals Business Overview
11.13.3 Enzon Pharmaceuticals Anti-fungal Drugs Introduction
11.13.4 Enzon Pharmaceuticals Revenue in Anti-fungal Drugs Business (2018-2023)
11.13.5 Enzon Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
